INTRODUCTION TO THE MACROGENICS CLASs ACTION LAWSUIT Call us today about the MacroGenics class action lawsuit for a free case evaluation
The MacroGenics class action lawsuit seeks to represent purchasers of MacroGenics, Inc. (NASDAQ: MGNX) publicly traded securities or sellers of MacroGenics puts between March 7, 2024 and May 9, 2024, inclusive (the “Class Period”). Captioned Crain v. MacroGenics, Inc., No. 24-cv-02184 (D. Md.), the MacroGenics class action lawsuit charges MacroGenics and MacroGenics’ Chief Executive Officer with violations of the Securities Exchange Act of 1934.
If you have suffered losses in MacroGenics stock and are interested in becoming the lead plaintiff in the MacroGenics class action lawsuit or have any inquiries regarding your rights as a shareholder, please reach out to MacroGenics Stock Loss Lawyer Timothy L. Miles at no cost. You can contact him by calling 855/846-6529, sending an e-mail to [email protected], or filling out a contact form. Lead plaintiff motions for the MacroGenics class action lawsuit must be filed with the court no later than September 24, 2024. In this guide, we will address the six fundamental concepts shareholders in the MacroGenics class action lawsuit need to know at this early stage of the litigation. what is THE LEAD PLAINTIFF DEADLINE IN THE CLASS ACTION against MacroGenics?
Lead plaintiff motions for the MacroGenics class action lawsuit must be filed with the court no later than September 24, 2024. When a securities class action is filed such as the MacroGenics class action lawsuit:
what is THE LEAD PLAINTIFF PROCESS IN THE MacroGenics CLASS ACTION LAWSUIT?
Under the Private Securities Litigation Reform Act of 1995 (PSLRA):
CAN A NON-U.S. INVESTOR SERVE AS LEAD PLAINTIFF IN THE MACROGENICS CLASS ACTION LAWSUIT?
Yes, courts in the U.S. have consistently recognized that non-U.S. investors, many of whom have substantial holdings, are adequate lead plaintiffs and have the same right to move for lead plaintiffs as U.S. investors. Thus, if a non-U.S. investor suffered losses in MacroGenics stock, they may move the Court to be appointed lead plaintiff in the MacroGenics class action lawsuit.
WHAT ARE THE BENEFITS OF SERVING AS A LEAD PLAINTIFF IN THE MacroGenics CLASS ACTION LAWSUIT?
WHAT ARE THE RESPONSIBILITIES THE LEAD PLAINTIFF WILL HAVE IN THE MacroGenics CLASS ACTION LAWSUIT?
WILL THE LEAD PLAINTIFFS GET MORE MONEY THAN CLASS MEMBERS IF THE MaCROGENICS CLASS ACTION LAWSUIT SETTLES? Call Timothy L. Miles now for a free case evaluation in the MacroGenics class action lawsuit
No, but they may be entitled to recover their reasonable expenses incurred with are directly related to representing the class in the MacroGenics class action lawsuit. Under the PSLAR, a Lead Plaintiff is only entitled to his or her pro rata share of any recovery and does not receive any additional money for serving as a representative party on behalf of the class. However, a court, in its discretion, may approve an award of “reasonable costs and expenses (including lost wages)” to a Lead Plaintiff that directly relates to the representation of the class in the MacroGenics class action lawsuit on behalf of investors who suffered losses in MacroGenics stock.
CONTACT MacroGenics STOCK LOSS LAWYER TODAY TIMOTHY L MILES TODAY ABOUT A MacroGenics CLASS ACTION LAWSUIT
If you suffered losses in MacroGenics stock, contact MacroGenics stock loss lawyer Timothy L. Miles today for a free case evaluation about a MacroGenics class action lawsuit. Call today and see what a MacroGenics stock loss lawyer could do for you if you suffered losses in MacroGenics stock. This will most likely be the only call you need to make. (855) 846–6529 or [email protected].
The Law Offices of Timothy L. Miles
Tapestry at Brentwood Town Center 300 Centerview Dr., #247 Brentwood, TN 37027 Phone: (855) 846–6529 Email: [email protected] MacroGenics stock loss lawyer Timothy L. Miles Nashville attorney Timothy L. Miles is a nationally recognized shareholder rights attorney raised in Nashville, Tennessee. Mr. Miles has dedicated his career to representing shareholders, employees, and consumers in complex class-action litigation. Whether serving as lead, co-lead, or liaison counsel, Mr. Miles has helped recover hundreds of millions of dollars for defrauded investors, shaped precedent-setting decisions, and delivered real corporate governance reforms. Judges and peers have repeatedly recognized Mr. Miles’ relentless advocacy for the underdog, as well as his unbendable ethical standards. Mr. Miles was recently selected by Martindale-Hubbell® and ALM as a 2022 Top Ranked Lawyer, 2022 Top Rated Litigator. and a 2022 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association,Class Action: Class Action: Top National Trial Lawyers, National Trial Lawyers Association (2023), a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019); a Top Rated Litigator by Martindale-Hubbell® and ALM (2019-2022); America’s Most Honored Lawyers 2020 – Top 1% by America’s Most Honored (2020-2022). Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, civil procedure, derivative actions, corporate takeover litigation, corporate formation, mass torts, dangerous drugs, and more. Please visit our website or call for free anytime. Comments are closed.
|
Hours |
|
